4.6 Article

Towards Splicing Therapy for Lysosomal Storage Disorders: Methylxanthines and Luteolin Ameliorate Splicing Defects in Aspartylglucosaminuria and Classic Late Infantile Neuronal Ceroid Lipofuscinosis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Clinical Neurology

Aspartylglucosaminuria: Clinical Presentation and Potential Therapies

Kimberly Goodspeed et al.

Summary: Aspartylglucosaminuria (AGU) is a rare recessively inherited neurodegenerative lysosomal storage disease characterized by progressive cognitive decline, skeletal abnormalities, connective tissue overgrowth, gait disturbance, and early mortality. Early recognition of clinical features such as developmental delays and characteristic physical traits is crucial for timely diagnosis and intervention in AGU cases. Early diagnosis, while currently lacking curative options, may still provide benefits through guidance, expectation management, interventions, and preparation for future disease-modifying therapies.

JOURNAL OF CHILD NEUROLOGY (2021)

Article Clinical Neurology

Risdiplam treatment has not led to retinal toxicity in patients with spinal muscular atrophy

Robert C. Sergott et al.

Summary: Evaluation of ophthalmologic safety in patients with spinal muscular atrophy (SMA) treated with risdiplam showed no retinal structural or functional changes, suggesting that safety ophthalmologic monitoring is not needed in these patients.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)

Article Biotechnology & Applied Microbiology

Pre-clinical Gene Therapy with AAV9/AGA in Aspartylglucosaminuria Mice Provides Evidence for Clinical Translation

Xin Chen et al.

Summary: The study demonstrates that treatment with AAV9/AGA is effective and safe for Aga(-/-) mice, leading to increased AGA activity, elimination of substrate accumulation, improved locomotor function, and neuroprotection. This treatment approach can also aid in the development of treatments for other lysosomal storage diseases.

MOLECULAR THERAPY (2021)

Article Medicine, General & Internal

Risdiplam in Type 1 Spinal Muscular Atrophy

Giovanni Baranello et al.

Summary: In a study involving 21 infants with type 1 spinal muscular atrophy, treatment with oral risdiplam resulted in increased levels of functional SMN protein in the blood. Infants in the high-dose group were more likely to sit without support for at least 5 seconds, and the higher dose of risdiplam was selected for the second part of the study.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Review Cell Biology

Regulation of RNA Splicing: Aberrant Splicing Regulation and Therapeutic Targets in Cancer

Koji Kitamura et al.

Summary: RNA splicing is a crucial process in the maturation of mRNA, allowing for diversity in mature mRNA through the inclusion and exclusion of introns and exons. Cancer cells develop cancer-specific mechanisms through abnormal splicing regulation to resist treatment and promote malignancy. Dysregulation of splicing is caused by factors such as mutations in splicing factors and changes in genomic sequences, impacting the splicing profile related to cancer.
Review Biochemistry & Molecular Biology

Regulating Divergent Transcriptomes through mRNA Splicing and Its Modulation Using Various Small Compounds

Ken-ichi Fujita et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Biochemistry & Molecular Biology

Therapeutic efficacy of antisense oligonucleotides in mouse models of CLN3 Batten disease

Jessica L. Centa et al.

NATURE MEDICINE (2020)

Correction Medicine, Research & Experimental

Luteolin, a flavonoid, as an anticancer agent: A review (vol 112, 108612, 2019)

Muhammad Imran et al.

BIOMEDICINE & PHARMACOTHERAPY (2019)

Article Medicine, General & Internal

Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease

J. Kim et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Multidisciplinary Sciences

Caffeine boosts Ataluren's readthrough activity

Laura Lentini et al.

HELIYON (2019)

Article Biochemistry & Molecular Biology

Readthrough of ACTN3 577X nonsense mutation produces full-length α-actinin-3 protein

Nagakatsu Harada et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)

Article Biochemistry & Molecular Biology

Amlexanox provides a potential therapy for nonsense mutations in the lysosomal storage disorder Aspartylglucosaminuria

Antje Banning et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)

Review Biochemistry & Molecular Biology

SR Proteins: Binders, Regulators, and Connectors of RNA

Sunjoo Jeong

MOLECULES AND CELLS (2017)

Review Respiratory System

Doxofylline is not just another theophylline!

Maria Gabriella Matera et al.

INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2017)

Review Neurosciences

The neuroprotective effects of caffeine in neurodegenerative diseases

Mahshad Kolahdouzan et al.

CNS NEUROSCIENCE & THERAPEUTICS (2017)

Article Biochemistry & Molecular Biology

A Splicing Reporter Tuned to Non-AG Acceptor Sites Reveals that Luteolin Enhances the Recognition of Non-canonical Acceptor Sites

Masanori Chiba et al.

CHEMICAL BIOLOGY & DRUG DESIGN (2016)

Article Clinical Neurology

Nusinersen potentially effective in SMA

Louise Adams

Nature Reviews Neurology (2016)

Review Genetics & Heredity

Aspartylglycosaminuria: a review

Maria Arvio et al.

ORPHANET JOURNAL OF RARE DISEASES (2016)

Review Biochemistry & Molecular Biology

Mechanisms and Regulation of Alternative Pre-mRNA Splicing

Yeon Lee et al.

ANNUAL REVIEW OF BIOCHEMISTRY, VOL 84 (2015)

Review Neurosciences

Luteolin as an anti-inflammatory and neuroprotective agent: A brief review

Seyed Fazel Nabavi et al.

BRAIN RESEARCH BULLETIN (2015)

Article Biochemistry & Molecular Biology

Methylxanthines Increase Expression of the Splicing Factor SRSF2 by Regulating Multiple Post-transcriptional Mechanisms

Jia Shi et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2015)

Article Biochemistry & Molecular Biology

SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice

James Palacino et al.

NATURE CHEMICAL BIOLOGY (2015)

Review Cell Biology

The RNAissance family: SR proteins as multifaceted regulators of gene expression

Jonathan M. Howard et al.

WILEY INTERDISCIPLINARY REVIEWS-RNA (2015)

Article Biochemistry & Molecular Biology

Caffeine induces tumor cytotoxicity via the regulation of alternative splicing in subsets of cancer-associated genes

Guan-Yu Lu et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2014)

Article Critical Care Medicine

Theophylline

Peter J. Barnes

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)

Article Multidisciplinary Sciences

Attenuation of Nonsense-Mediated mRNA Decay Enhances In Vivo Nonsense Suppression

Kim M. Keeling et al.

PLOS ONE (2013)

Article Multidisciplinary Sciences

Molecular basis for the action of a dietary flavonoid revealed by the comprehensive identification of apigenin human targets

Daniel Arango et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Editorial Material Immunology

A CASE SERIES OF A LUTEOLIN FORMULATION (NEUROPROTEK®) IN CHILDREN WITH AUTISM SPECTRUM DISORDERS

T. C. Theoharides et al.

INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2012)

Article Medicine, General & Internal

Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy

Nathalie M. Goemans et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Pediatrics

Kinetin Improves IKBKAP mRNA Splicing in Patients With Familial Dysautonomia

Felicia B. Axelrod et al.

PEDIATRIC RESEARCH (2011)

Editorial Material Biochemistry & Molecular Biology

Missed threads The impact of pre-mRNA splicing defects on clinical practice

Diana Baralle et al.

EMBO REPORTS (2009)

Review Chemistry, Medicinal

Distribution and Biological Activities of the Flavonoid Luteolin

Miguel Lopez-Lazaro

MINI-REVIEWS IN MEDICINAL CHEMISTRY (2009)

Article Behavioral Sciences

Assessment of luteolin (3',4',5,7-tetrahydroxyflavone) neuropharmacological activity

Miguel Coleta et al.

BEHAVIOURAL BRAIN RESEARCH (2008)

Article Biochemistry & Molecular Biology

Caffeine regulates alternative splicing in a subset of cancer-associated genes: A role for SC35

Jia Shi et al.

MOLECULAR AND CELLULAR BIOLOGY (2008)

Article Medicine, General & Internal

Local dystrophin restoration with antisense oligonucleotide PRO051

Judith C. van Deutekom et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Oncology

A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer

Margaret A. Gates et al.

INTERNATIONAL JOURNAL OF CANCER (2007)

Review Oncology

The enigmatic effects of caffeine in cell cycle and cancer

Ann M. Bode et al.

CANCER LETTERS (2007)

Article Genetics & Heredity

Therapeutic potential and mechanism of kinetin as a treatment for the human splicing disease familial dysautonomia

Matthew M. Hims et al.

JOURNAL OF MOLECULAR MEDICINE-JMM (2007)

Article Cardiac & Cardiovascular Systems

Dietary and serum vitamins and minerals as predictors of myocardial infarction and stroke in elderly subjects

J Marniemi et al.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2005)

Article Biochemistry & Molecular Biology

Rescue of a human mRNA splicing defect by the plant cytokinin kinetin

SA Slaugenhaupt et al.

HUMAN MOLECULAR GENETICS (2004)

Article Critical Care Medicine

Theophylline - New perspectives for an old drug

PJ Barnes

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)

Article Multidisciplinary Sciences

A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression

K Ito et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)

Article Microbiology

A fluorescence quenching test for the detection of flavonoid transformation

L Schoefer et al.

FEMS MICROBIOLOGY LETTERS (2001)

Article Biochemistry & Molecular Biology

Molecular pathogenesis of a disease: structural consequences of aspartylglucosaminuria mutations

J Saarela et al.

HUMAN MOLECULAR GENETICS (2001)